These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18760916)

  • 1. Practical advice on clinical decision making during neoadjuvant chemotherapy for primary breast cancer.
    Shenoy HG; Peter MB; Masannat YA; Dall BJ; Dodwell D; Horgan K
    Surg Oncol; 2009 Mar; 18(1):65-71. PubMed ID: 18760916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer.
    Rouzier R; Pusztai L; Garbay JR; Delaloge S; Hunt KK; Hortobagyi GN; Berry D; Kuerer HM
    Cancer; 2006 Oct; 107(7):1459-66. PubMed ID: 16948128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy for locally advanced breast cancer: a review of the literature and future directions.
    Mathew J; Asgeirsson KS; Cheung KL; Chan S; Dahda A; Robertson JF
    Eur J Surg Oncol; 2009 Feb; 35(2):113-22. PubMed ID: 18502088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy for breast cancer: does pretreatment axillary nodal staging improve decision making?
    Batsis C; Ziogas D; Fatouros M
    Ann Surg Oncol; 2009 Apr; 16(4):1063-4. PubMed ID: 19205806
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
    Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast tattoos for planning surgery following neoadjuvant chemotherapy.
    Lannin DR; Grube B; Black DS; Ponn T
    Am J Surg; 2007 Oct; 194(4):518-20. PubMed ID: 17826070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant systemic treatment of breast cancer.
    Makhoul I; Kiwan E
    J Surg Oncol; 2011 Mar; 103(4):348-57. PubMed ID: 21337570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are mastectomy rates a reasonable quality measure of breast cancer surgery?
    McCahill LE; Privette AR; Hart MR; James TA
    Am J Surg; 2009 Feb; 197(2):216-21. PubMed ID: 18614141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative chemotherapy for breast cancer.
    Buzdar AU
    Clin Adv Hematol Oncol; 2004 Apr; 2(4):212, 215. PubMed ID: 16163183
    [No Abstract]   [Full Text] [Related]  

  • 10. Pure and predominantly pure intralymphatic breast carcinoma after neoadjuvant chemotherapy: an unusual and adverse pattern of residual disease.
    Rabban JT; Glidden D; Kwan ML; Chen YY
    Am J Surg Pathol; 2009 Feb; 33(2):256-63. PubMed ID: 18936689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report of bilateral inflammatory breast cancer.
    Masannat YA; Peter M; Turton P; Shaaban AM
    Eur J Cancer Care (Engl); 2010 Jul; 19(4):558-60. PubMed ID: 19708943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
    Tanei T; Morimoto K; Shimazu K; Kim SJ; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2009 Jun; 15(12):4234-41. PubMed ID: 19509181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of international treatment guidelines and prognostic tests for the treatment of early breast cancer.
    Muñoz M; Estévez LG; Alvarez I; Fernández Y; Margelí M; Tusquets I; Seguí MA; Lluch A
    Cancer Treat Rev; 2008 Dec; 34(8):701-9. PubMed ID: 18922644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast conservation therapy for patients with locally advanced breast cancer.
    Alm El-Din MA; Taghian AG
    Semin Radiat Oncol; 2009 Oct; 19(4):229-35. PubMed ID: 19732687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast conservation in locally advanced breast cancer in developing countries: wise or waste.
    Tewari M; Krishnamurthy A; Shukla HS
    Surg Oncol; 2009 Mar; 18(1):3-13. PubMed ID: 18722112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer.
    Ah-See ML; Makris A; Taylor NJ; Harrison M; Richman PI; Burcombe RJ; Stirling JJ; d'Arcy JA; Collins DJ; Pittam MR; Ravichandran D; Padhani AR
    Clin Cancer Res; 2008 Oct; 14(20):6580-9. PubMed ID: 18927299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal and triple-negative breast cancers: impact on clinical decision-making and novel therapeutic options.
    Voduc D; Nielsen TO
    Clin Breast Cancer; 2008 Dec; 8 Suppl 4():S171-8. PubMed ID: 19158038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Better treatment for breast cancer in older patients.
    Tran P; Fentiman IS
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1081-90. PubMed ID: 19671028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
    Finnegan V; Parsons JT; Greene BD; Sharma V
    Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.